LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1

Journal of Cell Science

Volumn 129, Issue 1, 2016, Pages 51-64

  Zou, Chunbin ^a   Synan, Matthew J ^a   Li, Jin ^a   Xiong, Sheng ^b   Manni, Michelle L ^a   Liu, Yuan ^a   Chen, Bill B ^a   Zhao, Yutong ^a   Shiva, Sruti ^a   Tyurina, Yulia Y ^c   Jiang, Jianfei ^c   Lee, Janet S ^a   Das, Sudipta ^a   Ray, Anuradha ^a   Ray, Prabir ^a   Kagan, Valerian E ^a,c   Mallampalli, Rama K ^a,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JINAN UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Degradation; Mitochondria; Ubiquitin

Indexed keywords

ACYL COENZYME A LYSOCARDIOLIPIN ACYLTRANSFERASE 1; CARDIOLIPIN; F BOX PROTEIN; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; LIPOPOLYSACCHARIDE; MITOCHONDRIAL ENZYME; PEVONEDISTAT; PROTEIN FBXO28; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ACYLTRANSFERASE; LYSINE; LYSOCARDIOLIPIN ACYLTRANSFERASE, MOUSE; OXYGEN; UBIQUITIN;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DEACETYLATION; ENZYME DEGRADATION; ENZYME SUBSTRATE COMPLEX; ENZYME SUBUNIT; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG ALVEOLUS EPITHELIUM CELL; LYSOSOME; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DEPLETION; UBIQUITINATION; ANIMAL; BIOLOGICAL MODEL; CELL LINE; DRUG EFFECTS; ENZYMOLOGY; EPITHELIUM; GENE SILENCING; METABOLISM; PROTEIN DEGRADATION;

ACYLTRANSFERASES; ANIMALS; CARDIOLIPINS; CELL LINE; EPITHELIUM; GENE SILENCING; HISTONE DEACETYLASE 2; LIPOPOLYSACCHARIDES; LYSINE; LYSOSOMES; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; OXYGEN; PROTEOLYSIS; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN; UBIQUITINATION;

EID: 84959019199     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.176701     Document Type: Article

References (93)

1. Aapola, U., Liiv, I. and Peterson, P. (2002). Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity. Nucleic Acids Res. 30, 3602-3608.
2. Acehan, D., Khuchua, Z., Houtkooper, R. H., Malhotra, A., Kaufman, J., Vaz, F. M., Ren, M., Rockman, H. A., Stokes, D. L. and Schlame, M. (2009). Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria. Mitochondrion 9, 86-95.
3. Acehan, D., Vaz, F., Houtkooper, R. H., James, J., Moore, V., Tokunaga, C., Kulik, W., Wansapura, J., Toth, M. J., Strauss, A. et al. (2011). Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J. Biol. Chem. 286, 899-908.
4. Au, P. Y., Argiropoulos, B., Parboosingh, J. S. and Micheil Innes, A. (2014). Refinement of the critical region of 1q41q42 microdeletion syndrome identifies FBXO28 as a candidate causative gene for intellectual disability and seizures. Am. J. Med. Genet. A 164A, 441-448.
5. Baile, M. G., Sathappa, M., Lu, Y. -W., Pryce, E., Whited, K., McCaffery, J. M., Han, X., Alder, N. N. and Claypool, S. M. (2014). Unremodeled and remodeled cardiolipin are functionally indistinguishable in yeast. J. Biol. Chem. 289, 1768-1778.
6. Bissler, J. J., Tsoras, M., Göring, H. H. H., Hug, P., Chuck, G., Tombragel, E., McGraw, C., Schlotman, J., Ralston, M. A. and Hug, G. (2002). Infantile dilated X-linked cardiomyopathy, G4. 5 mutations, altered lipids, and ultrastructural malformations of mitochondria in heart, liver, and skeletal muscle. Lab. Invest. 82, 335-344.
7. Cai, R. L., Yan-Neale, Y., Cueto, M. A., Xu, H. and Cohen, D. (2000). HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins. J. Biol. Chem. 275, 27909-27916.
8. Cao, J., Liu, Y., Lockwood, J., Burn, P. and Shi, Y. (2004). A novel cardiolipinremodeling pathway revealed by a gene encoding an endoplasmic reticulumassociated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J. Biol. Chem. 279, 31727-31734.
9. Cao, J., Shen, W., Chang, Z. and Shi, Y. (2009). ALCAT1 is a polyglycerophospholipid acyltransferase potently regulated by adenine nucleotide and thyroid status. Am. J. Physiol. Endocrinol. Metab. 296, E647-E653.
10. Cardozo, T. and Pagano, M. (2004). The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5, 739-751.
11. Cepeda, D., Ng, H. -F., Sharifi, H. R., Mahmoudi, S., Cerrato, V. S., Fredlund, E., Magnusson, K., Nilsson, H., Malyukova, A., Rantala, J. et al. (2013). CDKmediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer. EMBO Mol. Med. 5, 1067-1086.
12. Chen, B. B. and Mallampalli, R. K. (2013). F-box protein substrate recognition: a new insight. Cell Cycle 12, 1009-1010.
13. Chen, B. B., Coon, T. A., Glasser, J. R. and Mallampalli, R. K. (2011). Calmodulin antagonizes a calcium-activated SCF ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis. Mol. Cell. Biol. 31, 1905-1920.
14. Chen, B. B., Coon, T. A., Glasser, J. R., Zou, C., Ellis, B., Das, T., McKelvey, A. C., Rajbhandari, S., Lear, T., Kamga, C. et al. (2014a). E3 ligase subunit Fbxo15 and PINK1 kinase regulate cardiolipin synthase 1 stability and mitochondrial function in pneumonia. Cell Rep. 7, 476-487.
15. Chen, Y., Li, J., Dunn, S., Xiong, S., Chen, W., Zhao, Y., Chen, B. B., Mallampalli, R. K. and Zou, C. (2014b). Histone deacetylase 2 (HDAC2) protein-dependent deacetylation of mortality factor 4-like 1 (MORF4L1) protein enhances its homodimerization. J. Biol. Chem. 289, 7092-7098.
16. Chen, H., Wu, D., Ding, X. and Ying, W. (2015a). SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. Neuroreport 26, 88-93.
17. Chen, W., Xiong, S., Li, J., Li, X., Liu, Y., Zou, C. and Mallampalli, R. K. (2015b). The ubiquitin E3 ligase SCF-FBXO24 recognizes deacetylated nucleoside diphosphate kinase A to enhance its degradation. Mol. Cell. Biol. 35, 1001-1013.
18. Choi, S. -Y., Gonzalvez, F., Jenkins, G. M., Slomianny, C., Chretien, D., Arnoult, D., Petit, P. X. and Frohman, M. A. (2007). Cardiolipin deficiency releases cytochrome c from the inner mitochondrial membrane and accelerates stimulielicited apoptosis. Cell Death Differ. 14, 597-606.
19. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V. and Mann, M. (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
20. Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E. and Mann, M. (2014). The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15, 536-550.
21. Chu, C. T., Ji, J., Dagda, R. K., Jiang, J. F., Tyurina, Y. Y., Kapralov, A. A., Tyurin, V. A., Yanamala, N., Shrivastava, I. H., Mohammadyani, D. et al. (2013). Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat. Cell Biol. 15, 1197-1205.
22. Claypool, S. M. and Koehler, C. M. (2012). The complexity of cardiolipin in health and disease. Trends Biochem. Sci. 37, 32-41.
23. Claypool, S. M., McCaffery, J. M. and Koehler, C. M. (2006). Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins. J. Cell Biol. 174, 379-390.
24. Claypool, S. M., Boontheung, P., McCaffery, J. M., Loo, J. A. and Koehler, C. M. (2008). The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome. Mol. Biol. Cell 19, 5143-5155.
25. Claypool, S. M., Whited, K., Srijumnong, S., Han, X. and Koehler, C. M. (2011). Barth syndrome mutations that cause tafazzin complex lability. J. Cell Biol. 192, 447-462.
26. Creery, D. and Fraser, D. D. (2002). Tissue dysoxia in sepsis: getting to know the mitochondrion. Crit. Care Med. 30, 483-484.
27. Díaz-Laviada, I., Ainaga, J., Portolés, M. T., Carrascosa, J. L., Muncio, A. M. and Pagani, R. (1991). Binding studies and localization of Escherichia coli lipopolysaccharide in cultured hepatocytes by an immunocolloidal-gold technique. Histochem. J. 23, 221-228.
28. Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K. and Benz, C. C. (2005). Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 45, 495-528.
29. Dudek, J., Cheng, I. -F., Balleininger, M., Vaz, F. M., Streckfuss-Bömeke, K., Hübscher, D., Vukotic, M., Wanders, R. J. A., Rehling, P. and Guan, K. (2013). Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome. Stem Cell Res. 11, 806-819.
30. Folch, J., Lees, M. and Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509.
31. Force, A. D. T., Ranieri, V. M., Rubenfeld, G. D., Thompson, B. T., Ferguson, N. D., Caldwell, E., Fan, E., Camporota, L. and Slutsky, A. S. (2012). Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526-2533.
32. Gonzalvez, F., D'Aurelio, M., Boutant, M., Moustapha, A., Puech, J. -P., Landes, T., Arnauné-Pelloquin, L., Vial, G., Taleux, N., Slomianny, C. et al. (2013). Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation. Biochim. Biophys. Acta 1832, 1194-1206.
33. Grönroos, E., Hellman, U., Heldin, C. H. and Ericsson, J. (2002). Control of Smad7 stability by competition between acetylation and ubiquitination. Mol. Cell 10, 483-493.
34. Gu, Z., Valianpour, F., Chen, S., Vaz, F. M., Hakkaart, G. A., Wanders, R. J. and Greenberg, M. L. (2004). Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome. Mol. Microbiol. 51, 149-158.
35. Henriksen, P., Wagner, S. A., Weinert, B. T., Sharma, S., Bacinskaja, G., Rehman, M., Juffer, A. H., Walther, T. C., Lisby, M. and Choudhary, C. (2012). Proteome-wide analysis of lysine acetylation suggests its broad regulatory scope in Saccharomyces cerevisiae. Mol. Cell. Proteomics 11, 1510-1522.
36. Houtkooper, R. H., Rodenburg, R. J., Thiels, C., van Lenthe, H., Stet, F., Poll-The, B. T., Stone, J. E., Steward, C. G., Wanders, R. J., Smeitink, J. et al. (2009a). Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal. Biochem. 387, 230-237.
37. Houtkooper, R. H., Turkenburg, M., Poll-The, B. T., Karall, D., Pérez-Cerdá, C., Morrone, A., Malvagia, S., Wanders, R. J., Kulik, W. and Vaz, F. M. (2009b). The enigmatic role of tafazzin in cardiolipin metabolism. Biochim. Biophys. Acta 1788, 2003-2014.
38. Huang, L. S., Mathew, B., Li, H., Zhao, Y., Ma, S. -F., Noth, I., Reddy, S. P., Harijith, A., Usatyuk, P. V., Berdyshev, E. V. et al. (2014). The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 189, 1402-1415.
39. Imae, R., Inoue, T., Nakasaki, Y., Uchida, Y., Ohba, Y., Kono, N., Nakanishi, H., Sasaki, T., Mitani, S. and Arai, H. (2012). LYCAT, a homologue of C. elegans acl-8, acl-9, and acl-10, determines the fatty acid composition of phosphatidylinositol in mice. J. Lipid Res. 53, 335-347.
40. Inuzuka, H., Gao, D., Finley, L. W. S., Yang, W., Wan, L., Fukushima, H., Chin, Y. R., Zhai, B., Shaik, S., Lau, A. W. et al. (2012). Acetylation-dependent regulation of skp2 function. Cell 150, 179-193.
41. Islam, M. N., Das, S. R., Emin, M. T., Wei, M., Sun, L., Westphalen, K., Rowlands, D. J., Quadri, S. K., Bhattacharya, S. and Bhattacharya, J. (2012). Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med. 18, 759-765.
42. Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K. and Reimann, J. D. (2000). The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 10, 429-439.
43. Jeger, V., Brandt, S., Porta, F., Jakob, S. M., Takala, J. and Djafarzadeh, S. (2015). Dose response of endotoxin on hepatocyte and muscle mitochondrial respiration in vitro. Biomed. Res. Int. 2015, 353074.
44. Kagan, V. E., Bayir, H. A., Belikova, N. A., Kapralov, O., Tyurina, Y. Y., Tyurin, V. A., Jiang, J., Stoyanovsky, D. A., Wipf, P., Kochanek, P. M. et al. (2009). Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic. Biol. Med. 46, 1439-1453.
45. Kagan, V. E., Chu, C. T., Tyurina, Y. Y., Cheikhi, A. and Bayir, H. (2014). Cardiolipin asymmetry, oxidation and signaling. Chem. Phys. Lipids 179, 64-69.
46. Kagan, V. E., Tyurina, Y. Y., Tyurin, V. A., Mohammadyani, D., Angeli, J. P. F., Baranov, S. V., Klein-Seetharaman, J., Friedlander, R. M., Mallampalli, R. K., Conrad, M. et al. (2015). Cardiolipin signaling mechanisms: collapse of asymmetry and oxidation. Antioxid. Redox Signal. 22, 1667-1680.
47. Kerner, J., Yohannes, E., Lee, K., Virmani, A., Koverech, A., Cavazza, C., Chance, M. R. and Hoppel, C. (2015). Acetyl-l-carnitine increases mitochondrial protein acetylation in the aged rat heart. Mech. Ageing Dev. 145, 39-50.
48. Kipreos, E. T. and Pagano, M. (2000). The F-box protein family. Genome Biol. 1, reviews3002-reviews3002. 7.
49. Kirkland, R. A., Adibhatla, R. M., Hatcher, J. F. and Franklin, J. L. (2002). Loss of cardiolipin and mitochondria during programmed neuronal death: evidence of a role for lipid peroxidation and autophagy. Neuroscience 115, 587-602.
50. Li, J., Romestaing, C., Han, X., Li, Y., Hao, X., Wu, Y., Sun, C., Liu, X., Jefferson, L. S., Xiong, J. et al. (2010). Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab. 12, 154-165.
51. Li, J., Liu, X., Wang, H., Zhang, W., Chan, D. C. and Shi, Y. (2012). Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression. Proc. Natl. Acad. Sci. USA 109, 6975-6980.
52. Li, S., Fossati, G., Marchetti, C., Modena, D., Pozzi, P., Reznikov, L. L., Moras, M. L., Azam, T., Abbate, A., Mascagni, P. et al. (2015). Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo. J. Biol. Chem. 290, 2368-2378.
53. Liu, X., Ye, B., Miller, S., Yuan, H., Zhang, H., Tian, L., Nie, J., Imae, R., Arai, H., Li, Y. et al. (2012). Ablation of ALCAT1 mitigates hypertrophic cardiomyopathy through effects on oxidative stress and mitophagy. Mol. Cell. Biol. 32, 4493-4504.
54. Liu, K. D., Wilson, J. G., Zhuo, H., Caballero, L., McMillan, M. L., Fang, X., Cosgrove, K., Calfee, C. S., Lee, J. -W., Kangelaris, K. N. et al. (2014). Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderatesevere acute respiratory distress syndrome. Ann. Intensive Care 4, 1334.
55. Loiacono, L. A. and Shapiro, D. S. (2010). Detection of hypoxia at the cellular level. Crit. Care Clin. 26, 409-421.
56. Lu, Y. -W. and Claypool, S. M. (2015). Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes. Front. Genet. 6, 3.
57. Martens, J. -C., Keilhoff, G., Gardemann, A. and Schild, L. (2014). Oxidation of cardiolipin is involved in functional impairment and disintegration of liver mitochondria by hypoxia/reoxygenation in the presence of increased Ca(2)(+) concentrations. Mol. Cell Biochem. 394, 119-127.
58. Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S. -J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P. et al. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222-230.
59. Pineau, B., Bourge, M., Marion, J., Mauve, C., Gilard, F., Maneta-Peyret, L., Moreau, P., Satiat-Jeunemaitre, B., Brown, S. C., De Paepe, R. et al. (2013). The importance of cardiolipin synthase for mitochondrial ultrastructure, respiratory function, plant development, and stress responses in Arabidopsis. Plant Cell 25, 4195-4208.
60. Popovic, D., Vucic, D. and Dikic, I. (2014). Ubiquitination in disease pathogenesis and treatment. Nat. Med. 20, 1242-1253.
61. Ray, N. B., Durairaj, L., Chen, B. B., McVerry, B. J., Ryan, A. J., Donahoe, M., Waltenbaugh, A. K., O'Donnell, C. P., Henderson, F. C., Etscheidt, C. A. et al. (2010). Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat. Med. 16, 1120-1127.
62. Ren, M., Phoon, C. K. L. and Schlame, M. (2014). Metabolism and function of mitochondrial cardiolipin. Prog. Lipid Res. 55, 1-16.
63. Roth, S. Y., Denu, J. M. and Allis, C. D. (2001). Histone acetyltransferases. Annu. Rev. Biochem. 70, 81-120.
64. Sadowski, M. and Sarcevic, B. (2010). Mechanisms of mono- and polyubiquitination: Ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine. Cell Div. 5, 19.
65. Schlame, M. (2013). Cardiolipin remodeling and the function of tafazzin. Biochim. Biophys. Acta. 1831, 582-588.
66. Schlame, M., Kelley, R. I., Feigenbaum, A., Towbin, J. A., Heerdt, P. M., Schieble, T., Wanders, R. J. A., DiMauro, S. and Blanck, T. J. (2003). Phospholipid abnormalities in children with Barth syndrome. J. Am. Coll. Cardiol. 42, 1994-1999.
67. Schlame, M., Ren, M., Xu, Y., Greenberg, M. L. and Haller, I. (2005). Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids 138, 38-49.
68. Schlattner, U., Tokarska-Schlattner, M., Ramirez, S., Tyurina, Y. Y., Amoscato, A. A., Mohammadyani, D., Huang, Z., Jiang, J., Yanamala, N., Seffouh, A. et al. (2013). Dual function of mitochondrial Nm23-H4 protein in phosphotransfer and intermembrane lipid transfer: a cardiolipin-dependent switch. J. Biol. Chem. 288, 111-121.
69. Shen, Z., Ye, C., McCain, K., Greenberg, M. L. (2015). The Role of Cardiolipin in Cardiovascular Health. BioMed Res. Int. 2015, 891707.
70. Sorice, M., Circella, A., Cristea, I. M., Garofalo, T., Di Renzo, L., Alessandri, C., Valesini, G. and Esposti, M. D. (2004). Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ. 11, 1133-1145.
71. Suryaraja, R., Anitha, M., Anbarasu, K., Kumari, G. and Mahalingam, S. (2013). The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner. Cell Death Dis. 4, e565.
72. Taunton, J., Hassig, C. A. and Schreiber, S. L. (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411.
73. Taylor, W. A. and Hatch, G. M. (2003). Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J. Biol. Chem. 278, 12716-12721.
74. Taylor, W. A. and Hatch, G. M. (2009). Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1). J. Biol. Chem. 284, 30360-30371.
75. Tyurina, Y. Y., Poloyac, S. M., Tyurin, V. A., Kapralov, A. A., Jiang, J., Anthonymuthu, T. S., Kapralova, V. I., Vikulina, A. S., Jung, M. -Y., Epperly, M. W. et al. (2014). A mitochondrial pathway for biosynthesis of lipid mediators. Nat. Chem. 6, 542-552.
76. Valianpour, F., Wanders, R. J. A., Overmars, H., Vreken, P., van Gennip, A. H., Baas, F., Plecko, B., Santer, R., Becker, K. and Barth, P. G. (2002). Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts. J. Pediatr. 141, 729-733.
77. Valianpour, F., Mitsakos, V., Schlemmer, D., Towbin, J. A., Taylor, J. M., Ekert, P. G., Thorburn, D. R., Munnich, A., Wanders, R. J., Barth, P. G. et al. (2005). Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J. Lipid Res. 46, 1182-1195.
78. Vreken, P., Valianpour, F., Nijtmans, L. G., Grivell, L. A., Plecko, B., Wanders, R. J. A. and Barth, P. G. (2000). Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279, 378-382.
79. Wang, G., McCain, M. L., Yang, L., He, A., Pasqualini, F. S., Agarwal, A., Yuan, H., Jiang, D., Zhang, D., Zangi, L. et al. (2014). Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and hearton-chip technologies. Nat. Med. 20, 616-623.
80. Wang, L., Liu, X., Nie, J., Zhang, J., Kimball, S. R., Zhang, H., Zhang, W. J., Jefferson, L. S., Cheng, Z., Ji, Q. et al. (2015). ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology 61, 486-496.
81. Whited, K., Baile, M. G., Currier, P. and Claypool, S. M. (2013). Seven functional classes of Barth syndrome mutation. Hum. Mol. Genet. 22, 483-492.
82. Wolffe, A. P. (1996). Histone deacetylase-a regulator of transcription. Science 272, 371.
83. Xu, Y., Sutachan, J. J., Plesken, H., Kelley, R. I. and Schlame, M. (2005). Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab. Invest. 85, 823-830.
84. Xu, Y., Condell, M., Plesken, H., Edelman-Novemsky, I., Ma, J., Ren, M. and Schlame, M. (2006a). A Drosophila model of Barth syndrome. Proc. Natl. Acad. Sci. USA 103, 11584-11588.
85. Xu, Y., Malhotra, A., Ren, M. and Schlame, M. (2006b). The enzymatic function of tafazzin. J. Biol. Chem. 281, 39217-39224.
86. Xu, S., Abbasian, M., Patel, P., Jensen-Pergakes, K., Lombardo, C. R., Cathers, B. E., Xie, W., Mercurio, F., Pagano, M., Giegel, D. et al. (2007). Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase. J. Biol. Chem. 282, 15462-15470.
87. Xu, Y., Zhang, S., Malhotra, A., Edelman-Novemsky, I., Ma, J., Kruppa, A., Cernicica, C., Blais, S., Neubert, T. A., Ren, M. et al. (2009). Characterization of tafazzin splice variants from humans and fruit flies. J. Biol. Chem. 284, 29230-29239.
88. Ye, C., Shen, Z. and Greenberg, M. L. (2014). Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function. J. Bioenerg. Biomembr., 1-11.
89. Zhao, Y., Zhou, P., Liu, B., Bambakidis, T., Mazitschek, R., Alam, H. B. and Li, Y. (2015). Protective effect of suberoylanilide hydroxamic acid against lipopolysaccharide-induced liver damage in rodents. J. Surg. Res. 194, 544-550.
90. Zhou, Q., Sims, P. J. and Wiedmer, T. (1998). Identity of a conserved motif in phospholipid scramblase that is required for Ca2+-accelerated transbilayer movement of membrane phospholipids. Biochemistry 37, 2356-2360.
91. Zou, C., Butler, P. L., Coon, T. A., Smith, R. M., Hammen, G., Zhao, Y., Chen, B. B. and Mallampalli, R. K. (2011a). LPS impairs phospholipid synthesis by triggering beta-transducin repeat-containing protein (beta-TrCP)-mediated polyubiquitination and degradation of the surfactant enzyme acyl-CoA: lysophosphatidylcholine acyltransferase I (LPCAT1). J. Biol. Chem. 286, 2719-2727.
92. Zou, C., Ellis, B. M., Smith, R. M., Chen, B. B., Zhao, Y. and Mallampalli, R. K. (2011b). Acyl-CoA:lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis. J. Biol. Chem. 286, 28019-28025.
93. Zou, C., Chen, Y., Smith, R. M., Snavely, C., Li, J., Coon, T. A., Chen, B. B., Zhao, Y. and Mallampalli, R. K. (2013). SCF(Fbxw15) mediates histone acetyltransferase binding to origin recognition complex (HBO1) ubiquitinproteasomal degradation to regulate cell proliferation. J. Biol. Chem. 288, 6306-6316.